Cresco Labs Inc

Cresco Labs has a liquidity ratio of 2.59, indicating a moderate ability to meet short-term obligations, but its free cash flow of -$128.74 million suggests ongoing cash outflows from operations. The company's debt-to-equity ratio of 1.32 reflects a leveraged capital structure, with long-term debt of $448.63 million against total equity of $340.45 million. Despite a cash and equivalents balance of $57.90 million, the company's net cash position is negative after subtracting total debt. Profitability metrics show a return on equity of -39.77% and a return on assets of -11.31%, indicating significant underperformance relative to industry norms. The company reported a net loss of $135.41 million and an operating loss of $45.49 million, with a gross profit of $324.57 million on revenue of $655.85 million. These figures suggest challenges in cost control and pricing power. Cresco Labs operates through multiple brands including Cresco, High Supply, Good News, and Remedi, with products sold in over 1,400 dispensaries across the U.S.. The company's revenue is concentrated in the cannabis retail and wholesale segments, with no disclosed geographic diversification beyond the U.S.. The company's revenue growth trajectory is uncertain, with no specific guidance provided in the outlook. However, the operating cash flow of $36.46 million indicates some operational resilience despite the net loss. Capital expenditures of -$38.18 million suggest ongoing investment in infrastructure and expansion. Risk factors include a medium liquidity risk due to negative free cash flow and a leveraged capital structure. The company has a low dilution risk, with no significant dilution sources identified in the risk assessment. However, the negative net cash position after subtracting total debt is a key flag. Recent events include analyst estimates with a mean price target of $2.22 and a median price target of $2.25, with 8 buy recommendations and no strong buy or hold recommendations. No specific recent filings or transcripts were provided in the input data to detail recent operational or strategic developments.